Coordinating efforts to reduce toxic algal bloom risks to Great Lakes communities
Admin Core
['FUNDING_P01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11364985
This program brings researchers and local communities together to prevent and reduce health risks from toxic blue-green algae around Lake Erie and nearby Great Lakes shores.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11364985 on ClinicalTrials.gov |
What this research studies
As a resident near the Great Lakes, I would rely on this program to coordinate research and community projects to understand and lower health risks from toxic algal blooms. It supports four integrated research projects plus a community engagement core and a facility core so researchers and local groups share data, budgets, and outreach plans. Center leaders meet regularly and an external advisory committee reviews progress to keep work focused on protecting water and public health. Results and guidance are shared with state agencies, water utilities, and community partners so warnings and fixes can reach people quickly.
Who could benefit from this research
Good fit: Ideal participants are community members, water utility staff, and people who live, work, or recreate near western Lake Erie and other affected Great Lakes shorelines.
Not a fit: People with no contact or reliance on Great Lakes waters or who live far from affected shorelines are unlikely to gain direct benefit.
Why it matters
Potential benefit: If successful, the work could lead to better warnings, safer drinking water, and actions that reduce people's exposure to toxic algal blooms in the Great Lakes region.
How similar studies have performed: Prior local studies and responses—such as actions taken after the 2014 Toledo water shutdown—have identified risks and protective steps, but this coordinated, community-centered center approach is broader and somewhat novel.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DICK, GREGORY JAMES — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: DICK, GREGORY JAMES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.